Wealth Enhancement Advisory Services LLC Raises Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Wealth Enhancement Advisory Services LLC lifted its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 11.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,589 shares of the company’s stock after buying an additional 356 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $253,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of IHE. EP Wealth Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $157,000. Jane Street Group LLC raised its position in iShares U.S. Pharmaceuticals ETF by 5.5% in the third quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock valued at $836,000 after purchasing an additional 616 shares during the period. Pinnacle Family Advisors LLC lifted its stake in shares of iShares U.S. Pharmaceuticals ETF by 75.8% during the third quarter. Pinnacle Family Advisors LLC now owns 11,595 shares of the company’s stock worth $819,000 after purchasing an additional 5,000 shares in the last quarter. Flow Traders U.S. LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the third quarter worth about $839,000. Finally, FMR LLC grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 10.9% in the third quarter. FMR LLC now owns 13,581 shares of the company’s stock valued at $959,000 after buying an additional 1,338 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 1.4 %

NYSEARCA IHE opened at $66.15 on Friday. The stock has a market cap of $668.12 million, a P/E ratio of 6.49 and a beta of 0.58. The company’s fifty day simple moving average is $67.24 and its 200-day simple moving average is $68.96. iShares U.S. Pharmaceuticals ETF has a 52 week low of $62.31 and a 52 week high of $72.94.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.